Our study shows that CD117 staining was significantly elevated in prostate tumors from high-grade patients, compared with low-grade, corresponding with previous reports demonstrating higher staining in patient bone metastases compared with the primary tumor. The gene discussed is KIT; the disease is prostate neoplasm.